Latest Kaiser Health News Stories
Advertising for hospitals, unlike pharmaceutical companies, doesn’t have to be backed up by data or facts. Cheerful messages of hope can feel like a slap in the face to a dying patient.
Las pruebas excesivas de cáncer de tiroides, próstata, seno y piel lleva a muchas personas mayores a someterse a tratamientos que no prolongarán sus vidas, pero que pueden causar dolor y sufrimiento innecesarios.
Overtreatment of breast cancer and other diseases is pervasive, burdening patients and the health care system with enormous costs and needless suffering.
The costs of using a new class of cancer treatments include far more than the drug’s sticker price.
Despite a lack of medical training, relatives increasingly are assigned complex, risky medical tasks at home, such as maintaining catheters. If done incorrectly, blood clots, infections, even death can result.
Un panel de expertos en prevención dice que las mujeres deberían alternar las pruebas de Papanicolau y VPH, en vez de hacerse las dos a la vez.
A draft recommendation from the U.S. Preventive Services Task Force says women between ages 30 and 65 should get a Pap test every three years or an HPV screening every five years, but they don’t need to do both.
Alrededor de un tercio de los pacientes con un tumor de tiroides de crecimiento lento, llamado cáncer de tiroides papilar, son elegibles para retrasar el tratamiento, según un nuevo estudio.
Study suggests that many small tumors are sleepy, not deadly.
The USA’s first approved gene therapy — to be used to fight leukemia that resists standard therapies — will cost $475,000 for a one-time treatment.
A través de la escritura expresiva, pacientes con cáncer logran canalizar sus miedos y ansiedades, y contar sus historias, en un inédito proceso creativo.
A breast cancer survivor and author has helped numerous patients explore the feelings awakened by their disease — and feel better.
El tratamiento con una nueva droga del laboratorio Novartis para casos en los que ha fracasado la quimioterapia o el trasplante de médula costaría $649,000.
A genetically altered cancer drug, based on CAR T-cell therapies, could be a big success with leukemia patients but at a staggering cost.
Although deaths from colorectal cancer are declining, researchers find rates of the disease among white men and women younger than 55 have spiked since the mid-1990s.
Thinking they were protected from insurance discrimination, many people got tested to see if they were likely to develop serious diseases. Legislation pushed by Republican leaders in Congress would leave them vulnerable.
Among hurdles: Older adults may have multiple illnesses that could complicate research or they might be unable to manage the commute.
As we get older, it helps to tickle the noggin with trivia. Here’s a pop quiz to see what you have learned as a regular reader of Kaiser Health News.
Muchas veces los pacientes con cáncer no reciben respuestas adecuadas a preguntas críticas, entre ellas, la más crucial y universal de todas.
Due to poor doctor-patient communication, most people with advanced cancer don’t know enough about their disease to make vital decisions.